Skip to main content
Veterinary Medicines

Valbazen 10%, 10 g/ 100 ml zawiesina doustna dla bydła i owiec

Authorised
  • Albendazole

Product identification

Medicine name:
Valbazen 10%, 10 g/ 100 ml zawiesina doustna dla bydła i owiec
Active substance:
  • Albendazole
Target species:
  • Cattle
  • Sheep
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Albendazole
    10.00
    gram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Milk
        84
        hour
      • Meat and offal
        7
        day
    • Sheep
      • Meat and offal
        8
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC11
Authorisation status:
  • Valid
Authorised in:
  • Poland
Available in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Polska Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Purna Pharmaceuticals
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 0796
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 15/11/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 15/11/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."